We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ERS Genomics and GenScript Biotech Corporation Sign CRISPR/Cas9 License Agreement

Product News   May 13, 2021

 
ERS Genomics and GenScript Biotech Corporation Sign CRISPR/Cas9 License Agreement
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent

Product News

ERS Genomics Limited has announced that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent. In addition, the JPO has allowed a third CVC patent which covers a chimeric version of the Cas9 protein.

READ MORE

GammaDelta Therapeutics Receives FDA Clearance For Novel Cell Cancer Therapy

Product News

GammaDelta Therapeutics has announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for the Company’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy,

READ MORE

Lonza launches Next Gen 4D-Nucleofector Cell Transfection Platform

Product News

Lonza has launched the next generation of its Nucleofector® Platform.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE